Skip to content
HomeJohnson & Johnson to Host Fourth-Quarter/Full-Year 2013 Earnings Meeting

Johnson & Johnson to Host Fourth-Quarter/Full-Year 2013 Earnings Meeting

Share Article
share to

New Brunswick, NJ (Dec. 18, 2013) - Johnson & Johnson (NYSE: JNJ) will host an analyst meeting at 8:30 a.m. (Eastern Time) on Tuesday, Jan. 21, to discuss fourth-quarter and full-year 2013 financial results. Alex Gorsky, Chairman of the Board of Directors and Chief Executive Officer; Dominic J. Caruso, Vice President, Finance and Chief Financial Officer; and Louise Mehrotra, Vice President, Investor Relations will host the meeting.

Investors and other interested parties may also access the meeting in the following ways:

  • The meeting will also be webcast and available through www.investor.jnj.com. The webcast is optimized for mobile streaming on iOS devices such as iPhones®, iPods®, and iPads®. A webcast and podcast replay will be available approximately two hours after the meeting concludes through www.investor.jnj.com.
  • Users of the Johnson & Johnson Investor Relations mobile app for the iPad® and iPhone® can also access the event. This free app is available in the iTunes® store and includes stock information, news releases, Company information, webcasts, SEC filings, the Company’s pharmaceutical product pipeline and Annual Reports, among other information.

About Johnson & Johnson
Caring for the world, one person at a time inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 128,700 employees at more than 275 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

###

Press Contacts:
Ernie Knewitz
(732) 524-6623
(917) 697-2318 (M)

Investor Contacts:
Louise Mehrotra
(732) 524-6491
Lisa Romanko
(732) 524-2034

You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.